ZNF519

Chr 18

zinc finger protein 519

Also known as: HsT2362

The protein is predicted to function as a DNA-binding transcription factor that regulates gene expression by binding to specific DNA sequences and chromatin. Mutations in ZNF519 have been associated with neurodevelopmental disorders including intellectual disability and developmental delay, with autosomal dominant inheritance. The gene shows low constraint against loss-of-function variants, suggesting some tolerance to disruption.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
1
Pubs (1 yr)
83
P/LP submissions
0%
P/LP missense
1.83
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryZNF519
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
79 unique Pathogenic / Likely Pathogenic· 78 VUS of 171 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.83LOEUF
pLI 0.008
Z-score 0.14
OE 0.92 (0.401.83)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.78Z-score
OE missense 1.13 (1.031.25)
302 obs / 266.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.92 (0.401.83)
00.351.4
Missense OE1.13 (1.031.25)
00.61.4
Synonymous OE0.85
01.21.6
LoF obs/exp: 3 / 3.3Missense obs/exp: 302 / 266.2Syn Z: 1.12
DN
0.92top 5%
GOF
0.86top 5%
LOF
0.2485th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

171 submitted variants in ClinVar

Classification Summary

Pathogenic78
Likely Pathogenic1
VUS78
Likely Benign5
Benign2
78
Pathogenic
1
Likely Pathogenic
78
VUS
5
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
78
0
78
Likely Pathogenic
0
0
1
0
1
VUS
0
68
10
0
78
Likely Benign
0
0
3
2
5
Benign
0
0
2
0
2
Total068942164

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ZNF519 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found